inSoma Bio
inSoma Bio, based in Durham, NC, develops innovative medical devices for reconstructive plastic surgery, focusing on bio-compatible materials that enable the use of a patient's own tissue.
Company Background
inSoma Bio operates in the healthcare industry, specifically focusing on medical devices. Established in Durham, NC, USA, the company boasts a small, dedicated team of four professionals. inSoma Bio participated in the Y-Combinator S20 batch, underscoring its innovative approach and startup DNA. The company is strategically located at the Bioengineering Research Initiative to Develop Global Entrepreneurs (BRiDGE) in downtown Durham, positioning it in a vibrant ecosystem of bioengineering talent and resources.
Innovative Medical Products
inSoma Bio develops cutting-edge products designed for reconstructive plastic surgery, enabling surgeons to utilize a patient's own tissue instead of synthetic implants and fillers for procedures like breast and facial reconstruction. These products involve genetically engineering protein-based materials to closely mimic those naturally found in the cellular environment. Unique attributes of these materials include bio-compatibility, porosity, mechanical support, and shapability. They assemble only with body heat, creating complex cellular environments through simple solution injections and are adaptable to contemporary medical procedures.
Technological Advantages
The technology by inSoma Bio offers several significant benefits. The materials are bio-compatible, porous, mechanically supportive, and moldable. They provide a natural, shapable scaffold that mimics actual tissue structures, stabilizing shapes and enhancing the effective volume of injected fat. Additional advantages include ease of vascularization and molecular-level control. The technology effectively bridges the gap between cost-effective manufacturing and the design control of synthetic polymers, with the natural tissue integration benefits of native proteins.
Target Markets
inSoma Bio primarily targets markets in the United States and Canada. The company's innovative approach appeals to the healthcare sector, specifically in areas needing bio-compatible materials for reconstructive plastic surgery. By addressing the drawbacks of current bio-compatible materials, which are often costly and side-effect-prone, inSoma Bio's products hold significant promise for widespread adoption in these regions.